APA (7th ed.) Citation

Pandey, A., Ahlawat, S., Singh, A., Singh, S., Murari, K., & Aryan, R. (2020, January). Outcomes and impact of minimal residual disease (MRD) in pediatric, adolescent and young adults (AYA) with acute lymphoblastic leukemia treated with modified MCP 841 protocol. Cancer Research, Statistics, and Treatment.

Chicago Style (17th ed.) Citation

Pandey, Avinash, Shivali Ahlawat, Anjana Singh, Shivkant Singh, Krishna Murari, and Raj Aryan. "Outcomes and Impact of Minimal Residual Disease (MRD) in Pediatric, Adolescent and Young Adults (AYA) with Acute Lymphoblastic Leukemia Treated with Modified MCP 841 Protocol." Cancer Research, Statistics, and Treatment Jan. 2020.

MLA (9th ed.) Citation

Pandey, Avinash, et al. "Outcomes and Impact of Minimal Residual Disease (MRD) in Pediatric, Adolescent and Young Adults (AYA) with Acute Lymphoblastic Leukemia Treated with Modified MCP 841 Protocol." Cancer Research, Statistics, and Treatment, Jan. 2020.